Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series

Arthritis Rheumatol. 2022 Jul;74(7):1302-1303. doi: 10.1002/art.42101. Epub 2022 May 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cyclosporine* / therapeutic use
  • Drug Therapy, Combination
  • Immunosuppressive Agents / therapeutic use
  • Interleukin-1*

Substances

  • Immunosuppressive Agents
  • Interleukin-1
  • Cyclosporine